'It's just ugly': Federal funding cuts to Columbia University leave chronic fatigue research in limbo
Earlier this month, Ian Lipkin, M.D., and his team at Columbia University submitted a paper for publication that suggests certain approved drugs could possibly be repurposed for a severe fatigue condition that currently has no approved treatment, while also highlighting prospective targets for new therapeutics. A week later, the NIH terminated grant funding to Columbia's center studying the condition.
